<SEC-DOCUMENT>0001104659-14-088001-index.html : 20141222
<SEC-HEADER>0001104659-14-088001.hdr.sgml : 20141222
<ACCEPTANCE-DATETIME>20141219183119
ACCESSION NUMBER:		0001104659-14-088001
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20141222
DATE AS OF CHANGE:		20141219
GROUP MEMBERS:		NOVARTIS AG

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioLineRx Ltd.
		CENTRAL INDEX KEY:			0001498403
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-86614
		FILM NUMBER:		141301023

	BUSINESS ADDRESS:	
		STREET 1:		P.O. BOX 45158
		STREET 2:		19 HARTUM STREET
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			91450
		BUSINESS PHONE:		972-2-548-9100

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 45158
		STREET 2:		19 HARTUM STREET
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			91450

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioLineRX, Ltd.
		DATE OF NAME CHANGE:	20100805

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVARTIS PHARMA AG
		CENTRAL INDEX KEY:			0001030617

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		LICHTSTRASSE 35
		STREET 2:		CH-4002
		CITY:			BASEL
		STATE:			V8
		BUSINESS PHONE:		212-830-2474

	MAIL ADDRESS:	
		STREET 1:		LICHTSTRASSE 35
		STREET 2:		CH-4002
		CITY:			BASEL
		STATE:			V8

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVARTIS INC
		DATE OF NAME CHANGE:	19970114
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>a14-26546_1sc13g.htm
<DESCRIPTION>SC 13G
<TEXT>
Document 1 - file: a14-26546_1sc13g.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g265461bii001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: g265461bii001.gif

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g265461bii002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: g265461bii002.gif

</DOCUMENT>
</SEC-DOCUMENT>